FrancophonIA/ELRC3.0 huggingface dataset:
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Fexeric's benefits are greater than its risks and recommended that it be approved for use in the EU.
Swedish: Kommittén för humanläkemedel (CHMP) fann att nyttan med Fexeric är större än riskerna och rekommenderade att Fexeric skulle godkännas för försäljning i EU.
English: What are the risks associated with Fexeric?
Swedish: Vilka är riskerna med Fexeric?
English: The most common side effects with Fexeric (which may affect more than 1 in 10 people) are changes in bowel movements (diarrhoea or constipation) and discoloured faeces.
Swedish: De vanligaste biverkningarna som orsakas av Fexeric (kan uppträda hos fler än 1 av 10 personer) är oregelbunden tarmtömning (diarré eller förstoppning) och missfärgad avföring.
English: Both studies looked at the change in the amount of phosphate in the blood, measured in mg/dl.
Swedish: Båda studierna undersökte förändringen av mängden fosfat i blodet, uppmätt i mg/dl.
English: In the first study, Fexeric was as effective as sevelamer carbonate, an approved medicine, in lowering phosphate levels in 359 patients with long-term kidney disease: after 12 weeks both treatments resulted in a reduction in phosphate levels of around 2 mg/dl.
Swedish: I den första studien var Fexeric lika effektivt som sevelamerkarbonat, ett godkänt läkemedel, när det gällde att sänka fosfatnivåerna hos 359 patienter med kronisk njursjukdom: efter 12 veckor resulterade båda behandlingarna i en sänkning av fosfatnivåerna på omkring 2 mg/dl.
English: What measures are being taken to ensure the safe and effective use of
Swedish: Vad görs för att garantera säker och effektiv användning av Fexeric?
English: A build-up of phosphate leads to hyperphosphataemia and in the long-term can cause complications such as heart
Swedish: En ansamling av fosfat leder till hyperfosfatemi som på lång sikt kan orsaka komplikationer såsom hjärt- och skelettsjukdom.
English: Fexeric must not be used in patients with low blood-phosphate levels, patients who have severe problems with the stomach and gut (such as bleeding from the gut), and those with iron accumulation disorders such as haemochromatosis.
Swedish: Fexeric får inte ges till patienter med låga fosfatnivåer i blodet, patienter med allvarliga mag- och tarmproblem (såsom blödning från tarmen) och patienter med järnackumuleringsrubbningar såsom hemokromatos.
English: The active substance in Fexeric, ferric citrate coordination complex, is a phosphate binder.
Swedish: Den aktiva substansen i Fexeric, järncitrat i koordinationskomplex, är en fosfatbindare.
English: For more information about treatment with Fexeric, read the package leaflet (also part of the EPAR) or contact
Swedish: Mer information om behandling med Fexeric finns i bipacksedeln (ingår också i EPAR).
English: When taken with meals, the iron contained in Fexeric binds to phosphate from food in the gut, forming a compound that is then eliminated in the stools.
Swedish: När det intas i samband med en måltid binder järnet i Fexeric till fosfat från födan i tarmen, och bildar en förening
English: Fexeric is a medicine used to control hyperphosphataemia (high levels of phosphate in the blood) in adults with long-term kidney disease.
Swedish: Fexeric är ett läkemedel som används för att kontrollera hyperfosfatemi (höga fosfatnivåer i blodet) hos vuxna med kronisk njursjukdom.
English: The CHMP considered that Fexeric is effective at controlling blood-phosphate levels in patients with long-term kidney disease, whether they are on dialysis or not.
Swedish: CHMP fann att Fexeric är effektivt när det gäller att kontrollera fosfatnivåerna i blodet hos patienter med kronisk njursjukdom, oavsett om de genomgår dialys eller inte.
English: Fexeric was shown to be effective at controlling blood-phosphate levels in 2 main studies in patients with long-term kidney disease and hyperphosphataemia.
Swedish: Fexeric visade sig vara effektivt när det gällde att kontrollera fosfatnivåerna i blodet i 2 huvudstudier på patienter med kronisk njursjukdom och hyperfosfatemi.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Fexeric, including the appropriate precautions to be followed by healthcare
Swedish: I enlighet med denna plan har säkerhetsinformation tagits med i produktresumén och bipacksedeln för Fexeric.
English: Patients should keep to their prescribed low
Swedish: Patienterna ska följa sin ordinerade diet med lågt fosfatintag.
English: It contains the active substance ferric citrate coordination
Swedish: Det innehåller den aktiva substansen järncitrat i koordinationskomplex.
English: For practical information about using Fexeric, patients should read the package leaflet or contact their
Swedish: Praktisk information om hur Fexeric ska användas finns i bipacksedeln.
English: For the full list of all side effects reported with
Swedish: En fullständig förteckning över biverkningar som rapporterats för Fexeric finns i bipacksedeln.
English: 20 January 2009
Swedish: 20 januari 2009
English: What is Sliwens?
Swedish: Vad är Sliwens?
English: It was to be available as tablets.
Swedish: Det skulle finnas som tabletter.
English: The company presented results of four main studies involving over 3,000 adults who had difficulty staying asleep.
Swedish: Företaget lade fram resultaten från fyra huvudstudier med över 3 000 vuxna som hade svårt att bibehålla sömnen.
English: The effects of Sliwens were first tested in experimental models before being studied in humans.
Swedish: Effekterna av Sliwens prövades först i olika experimentmodeller innan de studerades på människor.
English: The main measures of effectiveness were based on the amount of time the patients spent awake after they had first fallen asleep and improvements in the quality of sleep over the first four to 12 weeks of treatment.
Swedish: effektmåtten grundades på den tid som patienterna var vakna efter att först ha somnat samt förbättringen av sömnkvaliteten under de första fyra till tolv veckorna av behandlingen.
English: Sliwens is a medicine that contains the active substance eplivanserin.
Swedish: Sliwens är ett läkemedel som innehåller den aktiva substansen eplivanserin.
English: There was also a lack of information comparing the long-term use of Sliwens with placebo.
Swedish: Dessutom saknades information om effekten av långtidsanvändning av Sliwens jämfört med placebo.
English: The active substance in Sliwens, eplivanserin, is a 5-hydroxytryptamine receptor antagonist.
Swedish: Den aktiva substansen i Sliwens, eplivanserin, är en 5-hydroxytryptamin-receptorantagonist.
English: What was Sliwens expected to be used for?
Swedish: Vad skulle Sliwens användas för?
English: It was to be used in patients who have difficulty staying asleep.
Swedish: Det skulle ges till patienter som har svårt att bibehålla sömnen.
English: The CHMP considered the effect of Sliwens on sleep to be small.
Swedish: CHMP ansåg att Sliwens effekt på sömnen är liten.
English: On 18 December 2009, Sanofi-Aventis officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Sliwens, for use in adults with chronic (long-term) insomnia who have difficulty staying asleep.
Swedish: Den 18 december 2009 anmälde Sanofi-Aventis officiellt till Kommittén för humanläkemedel (CHMP) att man önskar dra tillbaka sin ansökan om godkännande för försäljning av Sliwens för behandling av kronisk (långvarig) sömnlöshet hos vuxna som har svårt att bibehålla sömnen.
English: Withdrawal of marketing authorisation application for Sliwens (eplivanserin)
Swedish: Återkallandet av ansökan om godkännande för försäljning för Sliwens (eplivanserin)
English: The company informed the CHMP that there were no consequences for patients in clinical trials or compassionate use, since all ongoing clinical trials have been discontinued.
Swedish: Företaget har informerat CHMP om att beslutet inte får några följder för patienter som deltar i kliniska prövningar eller humanitära program, eftersom alla pågående kliniska prövningar har avbrutits.
English: The studies compared Sliwens with placebo (a dummy treatment).
Swedish: I studierna jämfördes Sliwens med placebo (overksam behandling).
English: The Committee was also concerned about the risk of diverticulitis (inflammation in little sacs or pouches in the intestines) in patients taking the medicine.
Swedish: Dessutom var kommittén bekymrad över risken för divertikulit (inflammation i tarmfickor) hos patienter som tar läkemedlet.
English: How was Sliwens expected to work?
Swedish: Hur var det tänkt att Sliwens skulle verka?
English: It blocks receptors in the brain called 5-hydroxytryptamine type 2 receptors, which are involved in regulating the daily cycle of being asleep and being awake.
Swedish: Den blockerar receptorer i hjärnan kallade 5-hydroxytryptaminreceptorer av typ 2, som medverkar till att reglera perioderna av sömn och vakenhet under dygnet.
English: Withdrawal of marketing authorisation application for Sliwens (eplivanserin) EMA/23705/2010
Swedish: Återkallandet av ansökan om godkännande för försäljning för Sliwens (eplivanserin) EMA/139269/2010
English: Based on the review of the data and the company's response to the CHMP list of questions, at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Sliwens could not have been approved.
Swedish: Efter genomgången av de inlämnade uppgifterna och företagets svar på CHMP:s frågelista hyste CHMP vid tidpunkten för återkallandet vissa betänkligheter och ansåg preliminärt att Sliwens inte hade kunnat godkännas.
English: A fifth
Swedish: De viktigaste
English: By blocking these receptors, eplivanserin was expected to modify the sleep-wake cycle, helping people with long-term insomnia to stay asleep.
Swedish: Genom att blockera receptorerna skulle eplivanserin ändra på dessa perioder och hjälpa personer med kronisk sömnlöshet att bibehålla sömnen.
English: The letter from the company notifying the CHMP of the withdrawal of the application is available here.
Swedish: Företagets skrivelse till EMEA om sin önskan att dra tillbaka sin ansökan finns här.
English: study involving 283 adults compared Sliwens with lormetazepam (another medicine used to treat insomnia) looked at how sleepy the patients were the morning after taking Sliwens.
Swedish: I en femte studie med 283 vuxna jämfördes Sliwens med lormetazepam (ett annat läkemedel mot sömnlöshet).
English: Sliwens was expected to be used in adults with long-term insomnia (difficulty sleeping).
Swedish: Sliwens skulle användas för behandling av kronisk sömnlöshet hos vuxna.
English: 6th floor, ap 37+Sofia Bulgaria
Swedish: 6th floor, ap 37+Sofia
English: Zeletavská 1525/1
Swedish: Želetavská 1525/1
English: Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the Member States
Swedish: Förteckning över läkemedlets namn, läkemedelsformer, styrkor, administreringssätt av läkemedlen samt innehavare av godkännande för försäljning i medlemsstaterna
English: B-7860 Lessines Belgium
Swedish: B-7860 Lessines
English: VIOSER SA, 9th Km National Highway TrikalaLarissis,
Swedish: 9th Km National Highway TrikalaLarissis,
English: B-dul Theodor Pallady nr. 50, sector 3, Bucureşti,
Swedish: B-dul Theodor Pallady nr. 50, sector 3,
English: Leskoškova cesta 9D 1000 Ljubljana Slovenia
Swedish: Leskoškova cesta 9D 1000 Ljubljana
English: Box 35, Taxiarhes, Trikala,
Swedish: P.O. Box 35, Taxiarhes, Trikala,
English: BAXTER HELLAS Ltd, Metsovou 3, Neo Irakleion 14121, Athens Greece
Swedish: BAXTER HELLAS Ltd, Metsovou 3, Neo Irakleion 14121, Athens
English: UAB “BERLIN CHEMIE MENARINI BALTIC” Jasinskio 16a, LT-01112 Vilnius, Lithuania
Swedish: UAB “BERLIN CHEMIE MENARINI BALTIC” Jasinskio 16a, LT-01112 Vilnius,
English: Strada Fânarului nr. 2A, 500464 Braşov, Romania
Swedish: Strada Fânarului nr. 2A, 500464 Braşov,
English: Avenue Louis Pasteur ZA de Coignères Maurepas
Swedish: BAXTER S.A.S. Avenue Louis Pasteur ZA de Coignères Maurepas
English: 0.450.55 AV. MW 200K, sodium chloride
Swedish: 0.450.55 AV. MW 200K, natriumklorid
English: S.C. Fresenius Kabi Romania S.R.L, strada Fanarului nr. 2A, 500464 Brasov, Romania
Swedish: Rumänien S.C. Fresenius Kabi Romania S.R.L, strada Fanarului nr. 2A, 500464 Brasov,
English: Fresenius Kabi EOOD "Alexander Jendov" str.
Swedish: Bulgarien Fresenius Kabi EOOD 1 "Alexander Jendov" str.
English: Medias International d.o.o.
Swedish: Slovenien Medias International d.o.o.
English: Baxter S.p.A. Piazzale dell industria,
Swedish: Piazzale dell industria,
English: IP24 3SE United Kingdom
Swedish: IP24 3SE
English: Kruczkowskiego 8 00-380 Warszawa Poland
Swedish: Kruczkowskiego 8 00-380 Warszawa Poland hydroxietylstärkelse
English: S.C. INFOMED FLUIDS S.R.L.,
Swedish: Rumänien S.C. INFOMED FLUIDS S.R.L.,
English: Luxembourg Baxter S.A. Boulevard René Branquart 80
Swedish: Boulevard René Branquart 80
English: S.C. INFOMED FLUIDS S.R.L.
Swedish: Rumänien S.C. INFOMED FLUIDS S.R.L.
English: S.C. FRESENIUS KABI ROMÂNIA S.R.L.
Swedish: Rumänien S.C. FRESENIUS KABI ROMÂNIA S.R.L.
English: sodium chloride
Swedish: natriumklorid
English: BAXTER S.A.S.
Swedish: Baxter S.p.A.
English: 9th Km National Highway Trikal-Larissa, P.O.
Swedish: 9th Km National Highway Trikal-Larissa, P.O. Box 35, Taksiarhes Trikalon,
English: Baxter B.V.
Swedish: Nederländerna Baxter B.V.
English: Baxter Deutschland GmbH
Swedish: Bulgarien Baxter Deutschland GmbH,
English: Poly (O-2-hydroxyethyl) starch mol.
Swedish: poly-(O-2 hydroxietyl) stärkelse mol.
English: Serumwerk Bernburg AG
Swedish: Serumwerk Bernburg AG Hallesche Landstr.
English: Baxter d.o.o.
Swedish: Slovenien Baxter d.o.o.
English: Box 1110 +1120 DE-34209 Melsungen Germany
Swedish: B. Braun Melsungen AG P.O. Box 1110 +1120 DE-34209 Melsungen Germany
English: 60 g/l, 72 g/l, water ad 1000 ml
Swedish: 60 g/l, 72 g/l, vatten ad 1000 ml
English: 34212 Melsugen
Swedish: 34212 Melsungen,
English: 100 g/l, 9 g/l, water ad 1000 ml
Swedish: 100 g/l, 9 g/l, vatten ad 1000 ml
English: 69007 Lyon France hydroxyethyl starch 200
Swedish: 69007 Lyon France hydroxietylstärkelse 200 000 PLASMOHES 6%, solution pour perfusion
English: Baxter Deutschland GmbH, Edissonstrasse 4+Unterschleissheim,
Swedish: Baxter Deutschland GmbH Edisonstr.
English: 60 g/l, 9 g/l, water ad 1000 ml
Swedish: 60 g/l, 9 g/l, vatten ad 1000 ml
English: Fresenius Kabi Nederland B.V. Molenberglei 7 2627 Schelle Belgium active substance: hydroxyethyl starch (MR
Swedish: Fresenius Kabi NV Molenberglei 7 2627 Schelle Belgium hydroxietylstärkelse
English: Caxton Way, Thetford, Norfolk IP24 3SE United Kingdom
Swedish: Storbritannien Baxter Healthcare Limited, Caxton Way, Thetford, Norfolk IP24
English: Fresenius Kabi AB, 751 74 Uppsala Sweden hydroxyethyl starch,
Swedish: Fresenius Kabi AB, Rapsgatan 7, SE-751 74 Uppsala, Sweden hydroxietylstärkelse (HES), natriumklorid, vatten
English: 60 g/l, 0,3 g/l, 0,3 g/l, 6,02 g/l, 4,63 g/l, water ad 1000 ml
Swedish: 60 g/l, 0,3 g/l, 0,3 g/l, 6,02 g/l, 4,63 g/l, vatten ad 1000 ml
English: Poli(O-2-hydroxyethyl) starch
Swedish: poly-(O-2 hydroxietyl) stärkelse
English: Str.1, D34212 Melsungen, Germany
Swedish: D - 34212 Melsungen, Germany
English: Stella-Klein-Loew-Weg
Swedish: Baxter Healthcare GmbH Stella-Klein-Loew-Weg
English: Sodium Chlorid, Hydroxyethyl starch
Swedish: natriumklorid, hydroxietylstärkelse
English: Poly(0-2hydroxyethyl)starch 130 kDa mol.substitution 0,38-0,45 , Sodium acetate trihydrate, sodium chloride, potassium chloride, magnesium chloride hexahydrate
Swedish: poly-(O-2 hydroxietyl) stärkelse 130 kDa mol.substitution 0,38-0,45 , natriumacetat trihydrat, natriumklorid, kaliumklorid, magnesiumkloridhexahydrat
English: 0,134 g/l, 60 g/l, 0,4 g/l, 0,2 g/l, 6 g/l, 3,7 g/l, water ad 1000 ml
Swedish: 0,134 g/l, 60 g/l, 0,4 g/l, 0,2 g/l, 6 g/l, 3,7 g/l, vatten ad 1000 ml
English: United Kingdom poly(o-2hydroxyethyl)starch sodium acetate trihydrate sodium chloride potassium chloride magnesium chloride hexahydrate
Swedish: United Kingdom poly-(O-2 hydroxietyl) stärkelse natriumacetat trihydrat natriumklorid kaliumklorid magnesiumkloridhexahydrat
English: Poly(0-2hydroxyethyl)starch 130 kDa mol.substitution 0,38-0,45 , Sodium chloride
Swedish: poly-(O-2 hydroxietyl) stärkelse 130 kDa mol.substitution 0,38-0,45 , natriumklorid
English: B. BRAUN MELSUNGEN AG,
Swedish: Rumänien B. BRAUN MELSUNGEN AG,
English: 10000 Zagreb Croatia
Swedish: 1000 Ljubljana
English: B. Braun Melsungen AG Carl-Braun-Straße 1 34212 Melsungen Germany hydroxyethyl starch, Sodium chloride, Potassium chloride, Calcium chloride, Magnesium chloride hexahydrate, sodium acetate, Malic acid
Swedish: B. Braun Melsungen AG Carl-Braun Strasse 1 34212 Melsungen Germany hydroxietylstärkelse, natriumklorid, kaliumklorid, hydratiserad kalciumklorid, hydratiserad magnesiumklorid, hydratiserad natriumacetat, hydroxisuccinsyra
English: United Kingdom poly (o-2hydroxyethyl)starch sodium chloride
Swedish: United Kingdom poly-(O-2 hydroxietyl) stärkelse natriumklorid
English: 0,37 g/l, 100 g/l, 0,3 g/l, 0,2 g/l, 6,25 g/l, 3,27 g/l, 0,67 g/l, 1,197 g/l, water ad 1000 ml
Swedish: 0,37 g/l, 100 g/l, 0,3 g/l, 0,2 g/l, 6,25 g/l, 3,27 g/l, 0,67 g/l, 1,197 g/l, vatten ad 1000 ml
English: 0,37 g/l, 60 g/l, 0,3 g/l, 0,2 g/l, 6,25 g/l, 3,27 g/l, 0,67 g/l, 1,197 g/l, water ad 1000 ml
Swedish: 0,37 g/l, 60 g/l, 0,3 g/l, 0,2 g/l, 6,25 g/l, 3,27 g/l, 0,67 g/l, 1,197 g/l, vatten ad 1000 ml
English: Poly-(o-2-hydroxyethyl)starch (M.W 200000) + sodium acetate trihydrate + sodium chloride + potassium chloride + magnesium chloride hexahydrate
Swedish: Greece poly-(O-2 hydroxietyl)stärkelse (M.W 200000) + natriumacetat trihydrat + natriumklorid+ kaliumklorid magnesiumkloridhexahydrat
English: Poly(0-2hydroxyethyl)starch 200 kDa mol.substitution 0,43-0,55, Sodium chloride
Swedish: poly-(O-2 hydroxietyl) stärkelse 200 kDa mol.substitution 0,43-0,55, natriumklorid
English: Hydroxyethyl Starch 130/0,42, Sodium Chloride, Potassium Chloride, Calcium Chloride Dihydrate, Magnesium Chloride Hexahydrate, Sodium Acetate Trihydrate
Swedish: hydroxietylstärkelse 130/0,42, natriumklorid, kaliumklorid, kalciumkloriddihydrat, magnesiumkloridhexahydrat, natriumacetat trihydrat
English: 60 g/l, 6,020 g/l, 4,630 g/l, 0,300 g/l, 0,300 g/l
Swedish: 6,020 g/l, 4,630 g/l, 0,300 g/l, 0,300 g/l
English: Belgium B. Braun Melsungen AG Carl-Braun-Strasse 1
Swedish: Storbritannien B Braun Melsungen AG Carl-Braun-Strasse 1
English: Luxembourg Fresenius Kabi Deutschland GmbH 61346 Bad Homburg v.d.H
Swedish: Slovenien Fresenius Kabi Deutschland GmbH 61346 Bad Homburg v.d.H.
English: 100 g/l, 6,252 g/l, 3,266 g/l, 0,671 g/l, 0,368 g/l, 0,298 g/l, 0,203 g/l
Swedish: 6,252 g/l, 3,266 g/l, 0,671 g/l, 0,368 g/l, 0,298 g/l, 0,203 g/l
English: Sodium chloride, potassium chloride, magnesium chloride hexahydrate, sodium acetate trihydrate, malic acid, poly (0-2hydroxyethyl) starch, calcium chloride dihydrate
Swedish: natriumklorid, kaliumklorid, magnesiumkloridhexahydrat, natriumacetat trihydrat, äppelsyra, poly-(O-2 hydroxietyl) stärkelse, kalciumkloriddihydrat
English: Tetraspan 6% 60 g/l, 6,25 g/l, 0,3 g/l, 0,37 g/l,
Swedish: Tetraspan 6% 60 g/l, 6,25 g/l, 0,3 g/l, 0,37 g/l, 0,2 g/l,
English: Poly(0-2hydroxyethyl)starch 130 kDa mol.substitution 0,42 , Sodium chloride, Potassium chloride, Calcium chloride trihydrate, Magnesium chloride hexahydrate, sodium acetate trihydrate
Swedish: Belgium poly-(O-2 hydroxietyl) stärkelse 130 kDa mol.substitution 0,42 , natriumklorid, kaliumklorid, kalciumkloridtrihydrat, magnesiumkloridhexahydrat, natriumacetat trihydrat
English: Sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium acetate trihydrate, hydroxyethyl starch 130/0.42
Swedish: United Kingdom natriumacetat trihydrat, natriumklorid, kaliumklorid, magnesiumkloridhexahydrat, hydroxietylstärkelse 130/0.4
English: B. Braun Melsungen AG Carl-Braun-Strasse 1 34212 Melsungen Germany hydroxyethyl starch,
Swedish: B. Braun Melsungen AG Carl-Braun-Strasse 1 34212 Melsugen Germany natriumklorid, hydroxietylstärkelse
English: Hydroxyethyl Starch + Sodium Acetate Trihydrate + Sodium Chloride + Potasium Chloride + Magnesium Chloride Hexahydrate
Swedish: hydroxietylstärkelse + natriumacetat trihydrat + natriumklorid+ kaliumklorid magnesiumkloridhexahydrat
English: Fresenius Kabi Nederland B.V. Molenberglei 7 2627 Schelle Belgium active substance: hydroxyethyl starch (polymere 130/0.4) and sodium chloride
Swedish: Fresenius Kabi NV Molenberglei 7 2627 Schelle Belgium natriumklorid, hydroxietylstärkelse
English: Volulyte 6% 60 g/l, 4.63 g/l, 6.02 g/l, 0.30 g/l,
Swedish: Volulyte 6% 60 g/l, 4.63 g/l, 6.02 g/l, 0.30 g/l, 0.30 g/l
English: Belgium Fresenius Kabi NV Molenberglei 7
Swedish: Bulgarien Fresenius Kabi Deutschland GmbH Else-Kroner-Strasse 1
English: Polyhydroxyethylstarch, Sodium chloride
Swedish: Germany polyhydroxietylstärkelse, natriumklorid
English: Poly(0-2hydroxyethyl)starch 200 kDa mol.substitution 0,45-0,55, Sodium chloride
Swedish: D-34212 Melsungen poly-(O-2 hydroxietyl) stärkelse 200 kDa mol.substitution 0,45-0,55, natriumklorid
English: Volulyte 6% 60 g/l, 6,02 g/l, 4,63 g/l, 0,30 g/l,
Swedish: Volulyte 6% 60 g/l, 6,02 g/l, 4,63 g/l, 0,30 g/l, 0,30 g/l
English: ul.Hrubieszowska 2 01-209 Warszawa, Poland
Swedish: ul.Hrubieszowska 2 01-209 Warszawa, Poland poly-(O-2 hydroxietyl) stärkelse natriumklorid
English: Poly-(o-2-hydroxyethyl)starch (MW 200000) + Sodium Chloride + Potassium Chloride + Calcium Chloride Dihydrate +
Swedish: Greece poly-(O-2 hydroxietyl)stärkelse (MW 200000) + natriumklorid+ kaliumklorid + kalciumkloriddihydrat + magnesiumkloridhexahydrat + natriumacetat trihydrat + äppelsyra
English: Czech Republic hydroxyethyl starch, Sodium chloride, Potassium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Sodium acetate trihydrate
Swedish: Czech Republic hydroxietylstärkelse, natriumklorid, kaliumklorid, kalciumkloriddihydrat, magnesiumkloridhexahydrat, natriumacetat trihydrat
English: Sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate,sodium acetate trihydrate, malic acid, poly (0-2hydroxyethyl) starch
Swedish: natriumklorid, kaliumklorid, kalciumkloriddihydrat, magnesiumkloridhexahydrat, natriumacetat trihydrat, äppelsyra, poly-(O-2 hydroxietyl) stärkelse
English: HES, Sodium Chloride, Potassium Chloride, Calcium Chloride Dihydrate, Magnesium Chloride Hexahydrate, Sodium Acetate Trihydrate, Malic Acid
Swedish: HES, natriumklorid, kaliumklorid, kalciumkloriddihydrat, magnesiumkloridhexahydrat, natriumacetat trihydrat, äppelsyra
English: Tetraspan 6 % 60g/l, 6,25g/l, 0,30 g/l, 0.37 g/l,
Swedish: Tetraspan 6 % 60g/l, 6,25g/l, 0,30 g/l, 0.37 g/l, 0,20 g/l,
English: Tetraspan 10% 100 g/l, 6,25 g/l, 0,3 g/l, 0,37 g/l,
Swedish: Tetraspan 10% 100 g/l, 6,25 g/l, 0,3 g/l,
English: Luxembourg B.Braun Melsungen A.G. Carl-Braun-Straße 1
Swedish: Slovakien B. Braun Melsungen AG Carl-Braun-Straße 1
English: Tetraspan 10 % 100g/l, 6,25g/l, 0,30 g/l, 0.37 g/l,
Swedish: Tetraspan 10 % 100g/l, 6,25g/l, 0,30 g/l, 0.37 g/l, 0,20 g/l,
English: 60 g/l, 6,000 g/l, 3,700 g/l, 0,400 g/l, 0,200 g/l, 0,134 g/l
Swedish: 6,000 g/l, 3,700 g/l, 0,400 g/l, 0,200 g/l, 0,134 g/l
English: Poly(o-2-hydroxyethyl) Starch, Sodium Chloride
Swedish: poly-(O-2 hydroxietyl) stärkelse natriumklorid
English: Sodium Chloride, malic acid, Calcium Chloride, Potassium Chloride, Magnesium Chloride, Sodium acetate
Swedish: natriumklorid, kaliumklorid, magnesiumklorid, natriumacetat, saltsyra
English: Poly(O-2-hydroxyethyl) starch (HES), Sodium acetate trihydrate, Sodium chloride, Potassium chloride, Magnesium chloride hexahydrate
Swedish: poly-(O-2 hydroxietyl) stärkelse natriumacetat trihydrat, natriumklorid, kaliumklorid, magnesiumkloridhexahydrat
English: Poly(0-2hydroxyethyl)starch 130 kDa mol.substitution 0,42 , Sodium chloride
Swedish: D-34212 Melsungen poly-(O-2 hydroxietyl) stärkelse 130 kDa mol.substitution 0,42 , natriumklorid